NVCRpartner · Current intraday read unavailable
Filing receipt · ZLAB / NVCR
“In 2018, we granted Zai Lab (Shanghai) Co., Ltd.”
NVCR · partner
3 names are moving together; 100% are participating in the current session.
Observed intraday paths are not available for this group yet.
| TICKER | Company | Sector | Today | Observed activity |
|---|---|---|---|---|
| DCTH | Delcath Systems, Inc. | Healthcare | +1.8% | 1/5 observed active sessions |
| NVCR | NovoCure Limited | Healthcare | -3.4% | 3/5 observed active sessions |
| ACHV | Achieve Life Sciences, Inc. | Healthcare | +3.4% | 4/5 observed active sessions |
Cohort
3 namesParticipation
100% this sessionObserved history
6 daily buildsThis identity theme becomes less useful if activity narrows to one or two names instead of remaining broad across the cohort.
NVCRpartner · Current intraday read unavailable
Filing receipt · ZLAB / NVCR
“In 2018, we granted Zai Lab (Shanghai) Co., Ltd.”
NVCR · partner
NVCRtext peer · Current intraday read unavailable
No filing excerpt is available for this relationship.
NVCRpartner · Current intraday read unavailable
Filing receipt · MRK / NVCR
“KEYNOTE D58 was designed and is being conducted as part of a clinical collaboration between Novocure and MSD, a tradename of Merck & Co., Inc.”
NVCR · partner
NVCRtext peer · Current intraday read unavailable
No filing excerpt is available for this relationship.
NVCRtext peer · Current intraday read unavailable
No filing excerpt is available for this relationship.